Human IL-22BP PharmaGenie ELISA Kit (SBRS0759)

Quantitative measurement of human Interleukin-22 Binding Protein in translational research is supported by this PharmaGenie ELISA kit from Assay Genie, formulated for studies of the IL-22/IL-22BP axis in inflammatory disease. IL-22BP acts as a soluble decoy receptor that modulates IL-22 signaling in epithelial barriers, and accurate quantitation helps researchers interpret pathway activity in inflammatory bowel disease, psoriasis, hepatic injury models, and chronic barrier dysfunction contexts. The assay accepts cell culture supernatant samples as well as clinical plasma and serum specimens, supporting both in vitro cell-based work and pharmacodynamic biomarker analysis.

Each kit ships with pre-coated microplate wells, calibrated recombinant standards, biotinylated detection antibody, streptavidin-HRP reagents, and buffers configured for a full 96-assay workflow. Standards and reagents are provided in single-use vials to protect activity across the run; reconstituted standards should be kept refrigerated and applied within the working day. The procedure follows a standard microplate ELISA workflow compatible with common plate-reader instruments used in pharmaceutical screening programs.

Intended for research use only, this Assay Genie kit supports drug discovery efforts investigating IL-22 pathway modulation, including target engagement studies and downstream biomarker readouts in inflammatory disease models.